Chondramine® bioregulator of cartilaginous tissue .

Chondramine®
Bioregulator of cartilaginous tissue

Long-term investigations performed by the research team of the Institute resulted in creating a new class of geroprotectors – peptide bioregulators. The administration of peptide bioregulators enables effective prevention of premature ageing and therapy of age-related diseases.
For the correction of disorders and prevention of diseases of the musculoskeletal system caused by the pathology of connective tissue and cartilage structures was developed “Chondramine”.
It has a selective effect on cartilage cells and improves metabolic processes in chondrocytes, which protects the joints from various lesions and normalizes their work.
It actively affects the restoration of cartilage and connective tissue in arthritis, arthrosis, osteochondrosis, rheumatic diseases and injuries of the musculoskeletal system, reduces pain and joint stiffness.
It is recommended for people with increased physical exertion and doing sports, as well as the elderly to maintain the functions of the musculoskeletal system.

Indications:
Degenerative-dystrophic diseases of the joints of the extremities and the spine;
consequences of injuries of the joints and limbs;
arthropathies of various etiologies;
systemic connective tissue diseases;
pre- and postoperative periods during joint operations;
states after extreme physical exertion, as well as systemic prevention of bone and joint disorders in high-performance sports.

How to take (course of administration and dosage) :
1-3 tablets 2-3 times a day for 10-15 minutes before a meal, drinking water, not chewing. Course: 30–45 days. Repeated course in 3-6 months.
“Chondramine” can be easily combined with other food supplements and medicines.

Special instructions:
Individual intolerance to the components, pregnancy, breast-feeding.
Before use, it is recommended to consult with a specialist.

Presentation and Pack:
40 tablets in pack ;
155 mg each tablet .